Integrating Bioinformatics and Drug Sensitivity Analyses to Identify Molecular Characteristics Associated with Targeting Necroptosis in Breast Cancer and their Clinical Prognostic Significance

2024-12-1

TGF-β score based on silico analysis can robustly predict prognosis and immunological characteristics in lower-grade glioma: the evidence from multicenter studies

2024-12-1

Patent Selections

2024-12-1

Targeted Regulation of Osteoblasts and Osteoclasts in Osteosarcoma Patients by CSF3R Receptor Inhibition of Osteolysis Caused by Tumor Inflammation Based on Transcriptional Spectrum Analysis and Drug Library Screening

2024-12-1

CK2B is a Prognostic Biomarker and a Potential Drug Target for Hepatocellular Carcinoma

2024-12-1

Identification of the Roles of Coagulation-Related Signature and its Key Factor RABIF in Hepatoma Cell Malignancy

2024-12-1

Fatty Acid Metabolism Signature Contributes to the Molecular Diagnosis of a Malignant Gastric Cancer Subtype with Poor Prognosis and Lower Mutation Burden

2024-12-1

Upregulation of M6A Reader HNRNPA2B1 Associated with Poor Prognosis and Tumor Progression in Lung Adenocarcinoma

2024-12-1

Advanced Strategies of CAR-T Cell Therapy in Solid Tumors and Hematological Malignancies

2024-12-1

Comprehensive Genomic Analysis of Puerarin in Inhibiting Bladder Urothelial Carcinoma Cell Proliferation and Migration

2024-9-1

Co-delivery of siAPE1 and melatonin by 125I-loaded PSMA-targeted nanoparticles for the treatment of prostate cancer

2024-9-1

Characterization of the Prognosis and Tumor Microenvironment of Cellular Senescence-related Genes through scRNA-seq and Bulk RNA-seq Analysis in GC

2024-9-1

The m6A Reader IGF2BP2 Promotes Oral Squamous Cell Carcinoma Progression by Maintaining UCA1 Stability

2024-8-26

Comprehensive Analysis and Experimental Validation of TLL2 as a Potential New Prognostic Biomarker Associated with Immune Infiltration in Lung Adenocarcinoma

2024-8-26

Phosphofructokinase-1 in Cancer: A Promising Target for Diagnosis and Therapy

2024-8-21

Ligustilide Inhibits the PI3K/AKT Signalling Pathway and Suppresses Cholangiocarcinoma Cell Proliferation, Migration, and Invasion

2024-8-20

Ruthenium Complex Suppresses Proliferation of Residual Hepatocellular Carcinoma after Incomplete Radiofrequency Ablation Therapy

2024-8-12

Chebulinic Acid: An Incipient Anticancer Agent

2024-8-1

A Patent Review of Human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors as Anticancer Agents and their Other Therapeutic Applications (1999-2022)

2024-8-1

LncRNA FAM83H-AS1 Contributes to the Radio-resistance and Proliferation in Liver Cancer through Stability FAM83H Protein

2024-8-1

Competitive Effect of Overexpressed C-terminal of Snail-1 (CSnail) in Control of the Growth and Metastasis of Melanoma Cells

2024-8-1

Integrated Single-cell and Bulk RNA Sequencing Analysis Cross Talk between Ferroptosis-related Genes and Prognosis in Oral Cavity Squamous Cell Carcinoma

2024-8-1

1,3,4-Oxadiazoles as Anticancer Agents: A Review

2024-8-1

Adverse Effects of Gefitinib on Skin and Colon in a Lung Cancer Mouse Model

2024-8-1

PSMA PET/MR is a New Imaging Option for Identifying Glioma Recurrence and Predicting Prognosis

2024-8-1

Predictive Modelling of Overall Survival in Adult Patients with Primary Diffuse Large B-cell Lymphoma of the Breast Using the Surveillance, Epidemiology, and End Results (SEER) Database

2024-8-1

KRAS Pathways: A Potential Gateway for Cancer Therapeutics and Diagnostics

2024-8-1

Prognostic Value of Fatty Acid Metabolism-related Genes in Patients with Bladder Cancer

2024-8-1

From Multiple Myeloma to Acute Myeloid Leukemia: A Case Report of a 61-year-old Woman after 8 Years of Chemotherapy and Immunotherapy

2024-8-1

Patent Selections

2024-8-1

Identification of Immune Infiltration-related Molecular Features in Ovarian Cancer Patients and Experimental Validation of Immune Response Molecular Mechanisms through Integrated WGCNA, Machine Learning, and Single-cell Sequencing Analysis

2024-7-18

Epigallocatechin Gallate Derivative Y6 Reverses Oxaliplatin Resistance in Hepatocellular Carcinoma via Targeting the MiR-338-3p/HIF-1α/TWIST Axis to Inhibit EMT

2024-7-11

Tyrosine Kinase Inhibitor Lenvatinib Causes Cardiotoxicity by Inducing Endoplasmic Reticulum Stress and Apoptosis through Activating ATF6, IRE1α and PERK Signaling Pathways

2024-7-11

Fumarate-1 Mediates the Regulation of Mitochondrial Homeostasis by PGC-1α to Promote Cell Pyroptosis and Inhibit the Progression of Thyroid Cancer

2024-7-11

Radiotherapy Enhancing and Radioprotective Properties of Berberine: A Systematic Review

2024-7-9

Adhesin Component Member STAG2 Enhances Cisplatin Tolerance in Colorectal Cancer Cells through the Epithelial-Mesenchymal Transition Pathway

2024-7-3

The Synergistic Anti-tumor Effects of Evodiamine based on Animal Model Experiments: A Systematic Review and Meta-analysis

2024-7-2

Preclinical Effects Of Melatonin On The Development Of Ehrlich's Tumor: A Biochemical, Cognitive, And Molecular Approach

2024-6-21

Patents on PARP-1 Inhibitors for the Management of Cancer from 2017-2023

2024-6-13

Acknowledgements to Reviewers

2024-6-5

Patent Selections

2024-6-5

Regulation of Metastasis and Growth of Colorectal Cancer via Targeting the PTEN Pathway: An Update on the Progress of LncRNA MLLT4-AS1

2024-6-3

Construction and Identification of a Human Colorectal Adenoma Epithelial Cell Line by SV40 Large T-Antigen Transfection

2024-5-28

PDLIM1 Inhibits Chemoresistance by Blocking DNA Damage Repair in Gastric Cancer

2024-5-22

Development of a Prognostic Risk Model Based on Oxidative StressRelated Genes for Platinum-Resistant Ovarian Cancer Patients

2024-5-9

Structure-Based Virtual Screening Identifying Novel FOXM1 Inhibitors as the Lead Compounds for Glioblastoma

2024-5-9

Stem Cell Markers in Neoplasms and their Relationship with Progression-free and Overall Survival in Patients with Recurrence

2024-5-9

USP31 Activates the Wnt/β-catenin Signaling Pathway and Promotes Gastric Cancer Cell Proliferation, Invasion and Migration

2024-5-7

New 1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-2-phenylisoquinoline-1(2H)-ones as Phosphoinositide 3-kinase Inhibitors for Treating Cancer and Other Diseases

2024-5-1

Pulmonary Adenocarcinoma Patient with Complex Mutations on EGFR Benefits from Furmonertinib after Acquiring Gefitinib Resistance: A Case Report

2024-5-1